B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

[1]  A. Schuna.  Rituximab for the Treatment of Rheumatoid Arthritis , 2007, Pharmacotherapy.

[2]  B. Nikbin,et al.  Role of B cells in pathogenesis of multiple sclerosis. , 2007, International review of neurobiology.

[3]  L. Scott,et al.  Rituximab: in rheumatoid arthritis. , 2007, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

[4]  M. Krumbholz,et al.  B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation , 2006, Annals of neurology.

[5]  Ludwig Kappos,et al.  A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. , 2006, The New England journal of medicine.